Dr. Jacob Nashett, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4 Pleasant Ave, Tupper Lake, NY 12986 Phone: 518-359-3378 |
Ms. Eileen Dattola, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2445 State Route 30, Pharmacy, Tupper Lake, NY 12986 Phone: 518-359-4247 |
Babette Michelle Leblanc Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4 Pleasant Ave, Tupper Lake, NY 12986 Phone: 518-359-3378 Fax: 518-359-9424 |
Joan Skiff Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 94 Demars Blvd, Tupper Lake, NY 12986 Phone: 518-359-9173 Fax: 518-359-9198 |
Mr. Matthew S Warner, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4 Pleasant Ave, Tupper Lake, NY 12986 Phone: 518-359-3378 |
Darrell Barber, R.PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 94 Demars Blvd, Suite 2, Tupper Lake, NY 12986 Phone: 518-359-9173 |
Rodney G Bashant, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4 Pleasant Ave, Tupper Lake, NY 12986 Phone: 518-359-3378 |
News Archive
Comcast Corporation and Stand Up To Cancer (SU2C) have launched the second installment of musical assets for Stand Up 2 Cancer On Demand, the first-ever video-on-demand (VOD) initiative focused on broadening awareness and raising funds for innovative cancer research, which debuted on Comcast in December.
S*BIO Pte Ltd today announced that a fourth novel, potential best-in-class compound discovered and developed by S*BIO has entered a Phase 1 clinical trial. The initiation of the study for S*BIO's oral multi-kinase inhibitor, SB1317 or TG02, in patients with advanced/refractory hematologic malignancies has triggered a payment from S*BIO's development and commercialization partner for the program, Tragara Pharmaceuticals.
It is too early to change the standard treatment of appendicitis in U.S. adults to initial antibiotic therapy only, rather than surgical removal of the appendix, or appendectomy, authors of a new systematic review study conclude.
Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the solar energy production, medical diagnostics and sensors and biotechnology research and development tools businesses, announced today that certain patent applications related to its advanced tissue engineering technology platform, CellAlign™, have been filed.
› Verified 3 days ago